A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment.
第一单位:
a McClellan Veterans Medical Center; Central Arkansas Veterans Healthcare System ; Little Rock , AR USA.
作者:
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);DNA损伤(DNA Damage);疾病模型, 动物(Disease Models, Animal);抗药性, 肿瘤(Drug Resistance, Neoplasm);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);基因, BRCA1(Genes, BRCA1);人类(Humans);美法仑(Melphalan);小鼠(Mice);多发性骨髓瘤(Multiple Myeloma);肽核酸类(Peptide Nucleic Acids);Rad51重组酶(Rad51 Recombinase);S期(S Phase);转录, 遗传(Transcription, Genetic);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1080/15384047.2015.1040951
PMID
25996477
发布时间
2020-09-30
- 浏览35

Cancer biology & therapy
976-86页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文